Equities Research Analysts’ Updated EPS Estimates for June 10th (AAPL, ACGL, ADUS, ANIX, ARCB, ARGX, ASO, AUB, AXSM, BAESY)

Equities Research Analysts’ updated eps estimates for Tuesday, June 10th:

Apple (NASDAQ:AAPL) had its hold rating reiterated by analysts at Needham & Company LLC.

Apple (NASDAQ:AAPL) had its buy rating reiterated by analysts at Bank of America Co.. They currently have a $235.00 target price on the stock.

Apple (NASDAQ:AAPL) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $270.00 price target on the stock.

Arch Capital Group (NASDAQ:ACGL) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating. They currently have $100.00 price target on the stock, down from their previous price target of $106.00.

Addus HomeCare (NASDAQ:ADUS) had its outperform rating reaffirmed by analysts at Macquarie. The firm currently has a $133.00 target price on the stock.

Anixa Biosciences (NASDAQ:ANIX) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $10.00 target price on the stock.

ArcBest (NASDAQ:ARCB) was upgraded by analysts at Bank of America Co. from an underperform rating to a neutral rating. Bank of America Co. currently has $74.00 target price on the stock, up from their previous target price of $63.00.

argenx (NASDAQ:ARGX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $720.00 price target on the stock.

Academy Sports and Outdoors (NASDAQ:ASO) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $60.00 target price on the stock.

Atlantic Union Bankshares (NASDAQ:AUB) was upgraded by analysts at Raymond James from an outperform rating to a strong-buy rating. They currently have $41.00 price target on the stock, up from their previous price target of $37.00.

Axsome Therapeutics (NASDAQ:AXSM) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $180.00 target price on the stock.

BAE Systems (OTCMKTS:BAESY) was upgraded by analysts at Bank of America Co. from an underperform rating to a buy rating.

Best Buy (NYSE:BBY) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $90.00 price target on the stock.

Casey’s General Stores (NASDAQ:CASY) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $490.00 price target on the stock.

Cidara Therapeutics (NASDAQ:CDTX) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald.

Crane (NYSE:CR) had its buy rating reissued by analysts at DA Davidson. DA Davidson currently has a $200.00 target price on the stock.

Salesforce (NYSE:CRM) had its outperform rating reiterated by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $370.00 target price on the stock.

CoreWeave, Inc. Class A Common Stock (NASDAQ:CRWV) had its underperform rating reiterated by analysts at DA Davidson. The firm currently has a $36.00 target price on the stock.

Endava (NYSE:DAVA) had its buy rating reiterated by analysts at Guggenheim. They currently have a $25.00 price target on the stock.

Eagle Bancorp (NASDAQ:EGBN) was upgraded by analysts at Janney Montgomery Scott from a neutral rating to a buy rating. The firm currently has $24.00 target price on the stock.

Elevation Oncology (NASDAQ:ELEV) had its market perform rating reiterated by analysts at JMP Securities.

Elevation Oncology (NASDAQ:ELEV) had its neutral rating reissued by analysts at HC Wainwright.

Fair Isaac (NYSE:FICO) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $2,575.00 price target on the stock.

Flutter Entertainment (NYSE:FLUT) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $310.00 target price on the stock.

Globant (NYSE:GLOB) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $125.00 target price on the stock.

Keros Therapeutics (NASDAQ:KROS) was downgraded by analysts at Bank of America Co. from a buy rating to a neutral rating. The firm currently has $18.00 price target on the stock, down from their previous price target of $32.00.

Limoneira (NASDAQ:LMNR) was upgraded by analysts at Lake Street Capital from a hold rating to a buy rating. They currently have $23.00 price target on the stock.

Lipocine (NASDAQ:LPCN) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $8.00 price target on the stock.

Macerich (NYSE:MAC) was upgraded by analysts at Mizuho from a neutral rating to an outperform rating. They currently have $18.00 target price on the stock, down from their previous target price of $22.00.

Manhattan Associates (NASDAQ:MANH) was downgraded by analysts at Redburn Atlantic from a buy rating to a neutral rating. The firm currently has $200.00 target price on the stock, down from their previous target price of $270.00.

McDonald’s (NYSE:MCD) had its sell rating reissued by analysts at Redburn Atlantic. Redburn Atlantic currently has a $260.00 target price on the stock, down from their previous target price of $319.00.

NV5 Global (NASDAQ:NVEE) had its market perform rating reissued by analysts at CJS Securities.

The Pennant Group (NASDAQ:PNTG) had its overweight rating reissued by analysts at Stephens. They currently have a $35.00 price target on the stock.

QuantaSing Group (NASDAQ:QSG) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. The firm currently has $9.52 price target on the stock, up from their previous price target of $6.10.

Southern First Bancshares (NASDAQ:SFST) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $43.00 price target on the stock.

Taysha Gene Therapies (NASDAQ:TSHA) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $8.00 price target on the stock.

TechTarget (NASDAQ:TTGT) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. They currently have $8.00 price target on the stock, down from their previous price target of $18.00.

Tevogen Bio (NASDAQ:TVGN) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $10.00 target price on the stock.

Texas Roadhouse (NASDAQ:TXRH) had its equal weight rating reaffirmed by analysts at Stephens. Stephens currently has a $170.00 price target on the stock.

U-Haul Holding Co /NV/ (NYSE:UHAL) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

VinFast Auto (NASDAQ:VFS) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $6.00 target price on the stock.

VinFast Auto (NASDAQ:VFS) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $5.50 price target on the stock.

Varonis Systems (NASDAQ:VRNS) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $60.00 target price on the stock.

Warner Bros. Discovery (NASDAQ:WBD) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Warner Bros. Discovery (NASDAQ:WBD) had its buy rating reiterated by analysts at Guggenheim.

Yum! Brands (NYSE:YUM) was upgraded by analysts at Redburn Atlantic from a neutral rating to a buy rating. Redburn Atlantic currently has $177.00 target price on the stock, up from their previous target price of $145.00.